Daiwa Securities Group
AQST icon

Daiwa Securities Group’s Aquestive Therapeutics AQST Stock Holding History

Daiwa Securities Group’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-500
Closed -$3K – 1203
2025
Q4 		$3K Hold
500
– – ﹤0.01% 1267
2025
Q3 		$3K Hold
500
– – ﹤0.01% 1235
2025
Q2 		$2K Hold
500
– – ﹤0.01% 1205
2025
Q1 		$1K Buy
+500
New +$1.51K ﹤0.01% 1211
2019
Q4 		– Sell
-163
Closed -$1K – 1203
2019
Q3 		$1K Hold
163
– – ﹤0.01% 1147
2019
Q2 		$1K Hold
163
– – ﹤0.01% 1170
2019
Q1 		$1K Buy
+163
New +$1.14K ﹤0.01% 1158

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Daiwa Securities Group's AQST Position: Q1 2026 in Review

Daiwa Securities Group sold out of Aquestive Therapeutics (AQST) in Q1 2026, closing a stake of 500 shares — an estimated $3K sold.

Daiwa Securities Group first reported a position in AQST in Q1 2019 and held it in 7 quarters. The position peaked at $3K in Q4 2025. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • Daiwa Securities Group reported no remaining Aquestive Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 500 Aquestive Therapeutics shares in Q1 2026, an estimated $3K.
  • Daiwa Securities Group first reported a position in Aquestive Therapeutics in Q1 2019 and held it in 7 quarters.
  • Daiwa Securities Group's Aquestive Therapeutics position peaked at $3K in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.